Share this article on:

Nonspecific Secretory Immunity in HIV-Infected Patients With Oral Candidiasis

Bard E.; Laibe, S.; Clair, S.; Biichlé, S.; Millon, L.; Drobacheff, C.; Bettinger, D.; Seillès, E.; Meillet, D.
JAIDS Journal of Acquired Immune Deficiency Syndromes: November 1st, 2002
Articles: PDF Only

Summary:Buccal and digestive tract opportunistic infections occur frequently in patients infected by HIV. In this study, we measured lysozyme (Lz), lactoferrin (Lf), total IgA (T-IgA), and secretory IgA (S-IgA) levels to investigate nonspecific secretory immunity in HIV-infected patients with oral candidiasis. Serum, saliva, and stool samples were analyzed by time-resolved immunofluorometric assay for Lz and Lf levels and by enzyme-linked immunosorbent assay for T-IgA and S-IgA levels. Mean salivary Lf and T-IgA levels (66.50 mg/L and 0.10 g/L, respectively) and mean fecal Lf, T-IgA, and S-IgA outputs (0.87, 54.0, and 43.6 mg/d, respectively) were significantly higher in HIV-infected patients with oropharyngeal candidiasis than in HIVinfected patients without oropharyngeal candidiasis and healthy subjects. There was a modification in the molecular form rate, with a high increase in S-IgA and monomeric IgA transudation from the plasmatic compartment into salivary and digestive fluids and an increase in salivary Lf local synthesis by polymorphonuclear neutrophils. HIV infection appears to be associated with dysregulation of some of the nonspecific immune factors at the mucosal surface. Despite high saliva concentrations and high intestinal output, innate immunity was not able to stop yeast expansion in HIV-infected patients.

Address correspondence and reprint requests to Pr. Dominique Meillet, Laboratoire de Parasitologie-Mycologie (EA482), Faculté de Médicine-Pharmacie, 25030 Besançon Cedex, France; e-mail:

Manuscript received April 23, 2002; accepted July 23, 2002.

© 2002 Lippincott Williams & Wilkins, Inc.